AFIB stock traders are celebrating as the FDA clears its arrhythmia management product for commercialization. More
Articles
Don’t Follow Buffett Into Apple Stock Just Yet
Apple has been performing admirably in a tough environment, but as an investment, there's no need to have buyer's remorse with AAPL stock. More
Big-League Clean-Energy Acquisition Adds Fuel to Chevron Stock
If you're a yield seeker or a value hunter - or you're just in the market for a forward-looking energy firm - CVX stock fits the bill nicely. More
COST Stock: What to Know About the Costco Patio Umbrellas Recall
Costco (COST) stock is in the news today as investors react to news of a solar-powered patio umbrella recall over fire risks. More
Voyager Token (VGX) Crypto Prices Fall 15% on 3AC Default News
Voyager Digital, which is associated with the VGX crypto, announced that a company to which it had provided a loan had defaulted on that loan. More
DWAC Stock Falls 10% on New Truth Social SPAC Subpoenas
Truth Social's SPAC partner has received new subpoenas. Here's what it means for the already questionable future of DWAC stock. More
